欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	BE/H/0084/002
药品名称	Viraferon
活性成分	[No Active-Substance specified] 0.0 -
剂型	Powder for solution for injection
上市许可持有人	Schering-Plough NV/SA Rue de Stalle 73 1180 Bruxelles
参考成员国 - 产品名称	Belgium (BE)
互认成员国 - 产品名称	Germany (DE) Viraferon HSA containing 3 MIU/ml, powder for solution Denmark (DK) Viraferon HSA containing 3 MIU/ml, powder for solution Netherlands (NL) Viraferon HSA containing 3 MIU/ml, powder for solution Luxembourg (LU) Viraferon United Kingdom (Northern Ireland) (XI) Viraferon HSA containing 3 MIU/ml, powder for solution Ireland (IE) Viraferon HSA containing 3 MIU/ml, powder for solution Austria (AT) Viraferon HSA containing 3 MIU/ml, powder for solution France (FR) Viraferon HSA containing 3 MIU/ml, powder for solution Spain (ES) Viraferon HSA containing 3 MIU/ml, powder for solution Portugal (PT) Viraferon HSA containing 3 MIU/ml, powder for solution Italy (IT) Viraferon HSA containing 3 MIU/ml, powder for solution Greece (GR) Viraferon HSA containing 3 MIU/ml, powder for solution Sweden (SE) Viraferon HSA containing 3 MIU/ml, powder for solution Finland (FI) Viraferon HSA containing 3 MIU/ml, powder for solution
许可日期	2008/04/05
最近更新日期	2008/04/05
药物ATC编码	L03A IMMUNOSTIMULANTS
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载
市场状态	Positive